Navigation Links
Nicoya Lifesciences Accelerates Drug Discovery with New Product Release
Date:8/9/2018

Since their establishment in 2012, ambitions have been high at Nicoya Lifesciences. As a global leader in biotechnology and with a team nearly double its’ size from last year, the company is thrilled to announce the release of their new OpenSPR instrument. The sleek new OpenSPR turned heads and impressed crowds at a private product launch event during the annual Protein Society Symposium in Boston on July 11th.

Nicoya’s OpenSPR instrument is a highly sensitive biosensor, allowing scientists to better understand diseases and develop new drugs to treat them. With over 500 users in more than 25 different countries, the company continues helping scientists solve their toughest research challenges in both industry and academia. Nicoya is using nanotechnology to deliver on their promise — to provide cutting edge technology for a fraction of the price of competing products.

The new OpenSPR is a two channel system, offering double the measurement throughput and half the sample consumption. With their users in mind, Nicoya introduced several automated features in order to reduce errors, improve time to result, minimize downtime, and enhance data quality. “As a global leader in biotechnology, we obsess over creating the world’s most accessible and innovative products. We’re extremely proud of our team. They’ve worked around the clock to make the impossible possible and execute the vision of Nicoya. We’ve received extremely positive feedback and so much excitement from our users worldwide - it’s truly humbling to have so many great minds join our mission to help extend human lives” says Ryan Denomme, the company’s CEO and co-founder.

Since 2012, the OpenSPR has been featured in countless academic publications worldwide. This is no coincidence. The instrument has been specifically designed and perfected to save researchers from tedious, out-dated, and time consuming processes in order to publish faster. Despite the incredible advances they’ve made to date, #TeamNico says they’re just getting started.

About Nicoya Lifesciences Inc.
Launched in 2012, Nicoya Lifesciences is a Canadian biotechnology company whose mission is to extend human life by enabling deeper knowledge of the biological world. Nicoya Lifesciences instruments are used by hundreds of world-renowned researchers in over 25 different countries. Information about Nicoya Lifesciences can be found at http://www.nicoyalife.com

Social media
Twitter: @Nicoya_Life
Facebook: facebook.com/nicoyalifesciences
LinkedIn: linkedin.com/company/nicoya-lifesciences
Instagram: @nicoyalifesciences

Read the full story at https://www.prweb.com/releases/nicoya_lifesciences_accelerates_drug_discovery_with_new_product_release/prweb15678940.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. New Automated SPR from Nicoya Lifesciences Levels the Playing Field in Protein Science
2. UAS LifeSciences Announces the Launch of UP4™ Probiotics into Target Stores Nationwide
3. Androvia LifeSciences to Present Four Studies Focused on Male Infertility At 41st Annual Conference of the American Society of Andrology (ASA)
4. GenSight's Project Portfolio Management solution chosen by Integra Lifesciences, to enhance new product process
5. CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services
6. UAS LifeSciences to Donate to Women’s Non-Profit of Your Choice
7. UE LifeSciences Launches WeMustTry.com Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries
8. Covalent Metrology Accelerates Development of Advanced Materials with Better, Faster, Cheaper Data
9. Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets
10. PrecisionAg® Media’s New Vision Accelerates the Promise of Technology-Driven Agriculture
11. Guanabenz Accelerates ALS Disease Progression in Preclinical Laboratory Experiments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2018)... ... August 06, 2018 , ... PetPace , the makers of a smart ... today announced the launch of a groundbreaking study to identify and eventually predict problems ... study of pregnant dogs sponsored by PetPace and conducted by Dr. Smadar Tal, DVM, ...
(Date:7/31/2018)... ... July 31, 2018 , ... ZeptoMetrix™ Corporation (ZMC) ... its expanding CE/IVD product inventory. , “We are pleased today to introduce two ... remains entirely committed to fully support and provide our diagnostics industry with as ...
(Date:7/26/2018)... ... July 26, 2018 , ... Ariadne ... of a biofield energy treated nutraceutical to improve anti-inflammatory and immune function responses. ... assessed in the preclinical research, were significantly reduced. Results are as follows:, ...
(Date:7/25/2018)... ... 25, 2018 , ... Vium, Inc. http://www.vium.com , the ... Cloud approach to accelerate preclinical drug discovery and development, today announced the promotion ... appointment of Jeff Caron to the newly formed role of Senior Vice President ...
Breaking Biology Technology:
(Date:8/7/2018)... IRVINE, Calif. (PRWEB) , ... August 06, 2018 ... ... latest evolution of their highly successful business intelligence platform. Inspired by its medical ... streamline the entire user experience on-site. Among the many changes, SmartTRAK 3.0 touts ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... in our Austin office, has been named Practice Group Chair for the Pharmaceuticals ... to help continue growing Dickinson Wright’s healthcare and life sciences initiatives, and appreciate ...
(Date:8/1/2018)... ... ... Dr. Asher Kimchi, Founder and Chairman of the International Academy of ... the 23rd World Congress on Heart Disease held in Boston, MA, USA. In addition ... Fellowship Awards. , Dr. Asher Kimchi, together with Chairman Dr. John A. Elefteriades, headed ...
Breaking Biology News(10 mins):